Key result
Statin use for primary prevention was associated with lower central systolic, diastolic, and pulse pressures, with LDL-c reduction mediating 15-44% of the effect.
Why the study?
Does statin use and LDL-c reduction improve central and brachial blood pressures in a general cohort?
Observational (n=16,507)
Does statin use and LDL-c reduction improve central and brachial blood pressures in a general cohort?
Answers are grounded in this paper and cite their sources.
Statin use is associated with lower central and brachial blood pressures, an effect only partially mediated by LDL-c reduction, suggesting pleiotropic effects on pulsatile pressure components.
Central blood pressure may be a better predictor of cardiovascular disease than brachial pressure. Although statins reduce brachial pressure, their impact on central pressure remains unknown. Furthermore, whether this effect is mediated through a decrease in low-density lipoprotein cholesterol (LDL-c) is unknown. This study aims to characterize the association of statins and LDL-c with central and brachial blood pressures and to quantify their respective effects. Of the 20 004 CARTaGENE participants, 16 507 had available central blood pressure, LDL-c, and Framingham risk score. Multivariate analyses were used to evaluate the association between central pressure and LDL-c in subjects with or without statins. The impact of LDL-c on the association between statin and pressure parameters was determined through mediation analyses. LDL-c was positively associated with systolic and diastolic central pressure in nonusers (β=0.077 and 0.106; P <0.001) and in participants with statins for primary (β=0.086 and 0.114; P <0.001) and secondary prevention (β=0.120 and 0.194; P <0.003). Statins as primary prevention were associated with lower central systolic, diastolic, and pulse pressures (−3.0, −1.6, and −1.3 mm Hg; P <0.001). Mediation analyses showed that LDL-c reduction contributed to 15% of central systolic and 44% of central diastolic pressure changes associated with statins and attenuated 22% of the effects on central pulse pressure. Similar results were found with brachial pressure components. In conclusion, reduction of LDL-c was associated with only a fraction of the lower blood pressures in statin user and seemed to be mostly associated with improvement of steady (diastolic) pressure, whereas non–LDL-c–mediated pathways were mostly associated with changes in pulsatile pressure components.
No takes yet. Share an insight, caveat, or question.
Lamarche et al. (2018) reported an observational. Statins vs. Nonusers was evaluated on Central and brachial blood pressures (p=<0.001). Statin use for primary prevention was associated with lower central systolic, diastolic, and pulse pressures, with LDL-c reduction mediating 15-44% of the effect.
Synapse has enriched 10 related papers. Consider them for comparative context: